The Scotts Miracle-Gro Company (SMG) Bundle
You're looking at The Scotts Miracle-Gro Company (SMG) and asking the right question: who is actually buying this stock, and what's their play? Forget the retail noise; the real action is with the big money, where institutional investors hold a massive 74.07% of the shares, signaling a high-conviction, if slightly volatile, environment. In fiscal year 2025, the company reported full-year sales of $3.41 billion and net income of $145.2 million, a solid turnaround from the prior year's loss, which is why you see firms like FMR LLC making a huge move, adding over 1.56 million shares in Q2 2025 alone. But it's not a one-way street: the balance of 226 institutions adding shares versus 233 selling shows a serious debate on the street about the pace of their turnaround, especially as they navigate the divestiture of the Hawthorne segment. So, are the Vanguard Group Inc. and BlackRock, Inc.-two of the largest holders-betting on the strength of the core U.S. consumer business, or are they just waiting for the average analyst price target of $69.50 to materialize? Let's dig into the filings and see exactly what the smart money is doing and why. It's a classic margin-recovery story, but the devil is in the details.
Who Invests in The Scotts Miracle-Gro Company (SMG) and Why?
You want to know who is betting on The Scotts Miracle-Gro Company (SMG) right now, and why. The direct takeaway is that SMG is overwhelmingly controlled by institutional money and its founding family, who are largely playing a value-and-turnaround strategy centered on the core U.S. consumer business and a major margin recovery in fiscal year 2025.
The investor base is not a simple retail crowd; it's a mix of passive giants, active managers, and the Hagedorn family, who collectively own the vast majority of the company. It's a complex trade, but the focus is clear: a return to high-margin, predictable growth.
Key Investor Types: The Institutional and Insider Split
The Scotts Miracle-Gro Company's ownership structure is unusual for a public company, dominated by two major groups: institutional investors and the Hagedorn family (insiders). This split means the stock's movement is less about day-to-day retail sentiment and more about large-scale fund flows and family conviction.
As of late 2025, institutional investors-think pension funds, mutual funds, and endowments-hold between 64.46% and 74.07% of the outstanding shares. This high percentage is typical for a large-cap company, but what's unique is the massive insider stake. For example, Robert Hagedorn, a key insider, owns approximately 26.83% of the company, with the Hagedorn Partnership LP holding an additional significant amount. That's a powerful alignment of interests, defintely.
- Institutional Investors: Own the majority; primarily passive and active funds.
- Insider/Family: Holds a massive stake, aligning management's long-term focus.
- Retail Investors: Account for a small fraction of the total float.
The top institutional holders are the usual suspects in the passive world, including Vanguard Group Inc. and BlackRock, Inc., who hold shares primarily through index funds like the iShares Core S&P Mid-Cap ETF.
Investment Motivations: The 2025 Turnaround Story
Investors are attracted to The Scotts Miracle-Gro Company for three main reasons: a strong core business recovery, dramatic margin expansion, and a clear path to increased capital return.
The core U.S. Consumer segment is the bedrock. For the full fiscal year 2025, the company reported adjusted EBITDA of $581.1 million, which was within the reaffirmed guidance of $570 million to $590 million. This financial recovery is driven by:
- Margin Surge: Adjusted gross margin expanded by a substantial 490 basis points to 31.2% in fiscal 2025, driven by cost-saving initiatives.
- Core Growth: U.S. Consumer net sales saw a 1% increase for the year, excluding non-recurring sales, with consumer takeaway units up 12.1% in the first half of FY2025.
- E-commerce Traction: The digital side is booming, with e-commerce sales growing a staggering 51% in fiscal 2025, now representing 10% of total sales.
Plus, the dividend is back in focus. The company declared a quarterly cash dividend of $0.66 per share, payable in December 2025. Management also signaled a multi-year share buyback program of $500 million to $1 billion starting in fiscal 2026, which is a major tailwind for earnings per share (EPS).
Investment Strategies: Playing the Recovery and Deleveraging
The strategies employed by these large investors reflect the company's ongoing transformation, particularly the complex cleanup of the Hawthorne segment (hydroponics and indoor growing). You see a mix of long-term holding, value investing, and event-driven trading.
Value and Turnaround Investing: This is the dominant active strategy. Investors here are betting on the company achieving its strategic goals, mainly reducing debt and simplifying the business. The company is targeting a leverage ratio (debt-to-EBITDA) to drop below 3.5x by the end of fiscal 2027. The successful completion of over $100 million in cost-outs in fiscal 2025 is a concrete sign the turnaround is working. This strategy is a patient bet on the core lawn and garden business returning to its historical profitability.
Passive/Index Holding: This is straightforward. Funds like BlackRock and Vanguard hold the stock because it's included in major indices, like the S&P MidCap 400. They are long-term holders by mandate, providing a stable floor for the stock price.
Event-Driven Trading: Some hedge funds are trading around the Hawthorne divestiture and the preservation of a significant $600 million tax benefit tied to that segment. They are looking to profit from the successful execution of this complex strategic move, which is expected to eliminate financial drama and allow the company to focus on its high-margin consumer brands.
Here's the quick math on the 2025 earnings momentum:
| Metric (Fiscal Year 2025) | Value/Range | Significance |
|---|---|---|
| Adjusted EBITDA | $581.1 million | Strong operational recovery. |
| Adjusted EPS Growth (YoY) | 63% (to $3.74/share) | Substantial earnings momentum. |
| Adjusted Gross Margin | 31.2% (+490 bps YoY) | Proof of cost-saving and mix shift success. |
| Quarterly Dividend | $0.66 per share | Commitment to shareholder returns. |
To be fair, the stock still faces execution risk, especially with the Hawthorne cleanup and reliance on a few major retail partners. But the numbers show the financial recovery in fiscal 2025 was real. You can dive deeper into the financial mechanics of this recovery here: Breaking Down The Scotts Miracle-Gro Company (SMG) Financial Health: Key Insights for Investors
Next step: Check the latest 13F filings for the most recent institutional buying/selling activity to see if the conviction around the turnaround is strengthening or weakening.
Institutional Ownership and Major Shareholders of The Scotts Miracle-Gro Company (SMG)
You need to know who truly controls The Scotts Miracle-Gro Company (SMG) and what they're doing with their capital. The direct takeaway is that institutional investors-the big money-hold the vast majority of the company, with their recent activity showing a slight net reduction in shares, signaling caution as they wait for the company's strategic turnaround to fully materialize.
As of late 2025, institutional investors, which include mutual funds and pension funds, own a substantial portion of the company, controlling approximately 74.07% of the outstanding stock. This high level of institutional ownership means their collective trading decisions heavily influence the stock price, and their demands often shape the company's strategic direction, particularly concerning capital allocation and debt management. You can see the full context of their business in The Scotts Miracle-Gro Company (SMG): History, Ownership, Mission, How It Works & Makes Money.
Top Institutional Investors and Their Stakes
The Scotts Miracle-Gro Company (SMG) has a broad base of 827 institutional owners, holding a total of over 48.2 million shares. The top holders are largely passive index and large-cap fund managers, which is typical for a company of this size. Their investment is often tied to the company's inclusion in major indices like the S&P Mid-Cap 400, which drives mandatory buying.
Here's a look at the largest shareholders based on their filings as of September 30, 2025, which represents the end of the third calendar quarter.
| Institutional Investor | Shares Held (as of 9/30/2025) | Value (Approx.) |
|---|---|---|
| Vanguard Group Inc. | 4,787,282 | ~$271.6 million |
| BlackRock, Inc. | 4,318,697 | ~$245.0 million |
| Earnest Partners Llc | 3,608,593 | ~$204.7 million |
| State Street Corp. | 1,506,039 | ~$85.4 million |
| Northern Trust Corp. | 1,387,496 | ~$78.7 million |
Here's the quick math: with the stock price around $56.73 per share in mid-November 2025, the total institutional value is approximately $2.78 billion.
Recent Shifts in Institutional Ownership
The recent trend shows a slight cooling from the institutional side. In the most recent reported quarter, the total number of institutional shares (long positions) saw a net decrease of 3.42%, equating to a reduction of roughly 1.71 million shares. This net selling suggests that while the largest holders remain committed, some are trimming their positions or rebalancing their funds.
To be fair, the picture is mixed. While Vanguard Group Inc. and BlackRock, Inc. reduced their stakes by 2.79% and 0.238%, respectively, other firms were actively buying. For instance, Ameriprise Financial Inc. increased its holdings by 265,677 shares, and Los Angeles Capital Management LLC boosted its stake by a substantial 663.8% in the second quarter of 2025. This is a defintely a sign of divergence in professional opinion.
The Role of Large Investors in SMG's Strategy
These large investors play a crucial role because their capital is what funds the company's strategic pivot. The Scotts Miracle-Gro Company (SMG) has been intensely focused on fiscal discipline, a strategy large shareholders demand. This includes the 'Project Springboard' cost-cutting initiative and a strong focus on debt reduction. Their continued support hinges on the execution of these plans.
Key financial targets institutional investors are tracking for the full 2025 fiscal year include:
- Achieving Adjusted EBITDA of $570 million to $590 million.
- Reducing net leverage, which dropped from 6.95x in 2024 to 4.41x in Q2 2025.
- Delivering adjusted Earnings Per Share (EPS) of at least $3.50 (management's target is higher, at $4.15-$4.35).
- Maintaining the annualized dividend of $2.64, which offers a dividend yield of around 4.7%.
What this estimate hides is the risk in the high dividend payout ratio, which is roughly 109% based on analyst EPS estimates, a figure that requires careful monitoring. Institutional investors provide stability, but they also apply pressure for consistent operational improvements, especially in the struggling Hawthorne Gardening subsidiary. Their patience is tied directly to the company's ability to hit these financial goals.
Key Investors and Their Impact on The Scotts Miracle-Gro Company (SMG)
You want to know who is really calling the shots at The Scotts Miracle-Gro Company (SMG) and why they're buying or selling. The short answer is that while institutional money dominates, the company's direction is still heavily influenced by its founding family, but that influence is being tested by the market's demand for a cleaner, less volatile business model.
Institutional investors hold about 74.07% of the stock, but the Hagedorn family, through the Hagedorn Partnership LP, remains the single largest shareholder, holding a significant 22.89% stake, or over 13.2 million shares, as of September 2025. This family ownership acts as a stabilizing force but also means major strategic shifts must align with their long-term vision. The real action, though, is in the massive movements by the big funds, which are pushing for a pure-play consumer goods focus.
The Institutional Heavyweights: Vanguard, BlackRock, and FMR
The top institutional holders are the passive giants, which is typical for a company of this size. They buy because The Scotts Miracle-Gro Company (SMG) is a staple in key indices (like the S&P Mid-Cap 400), but their sheer size gives them enormous influence in governance matters, even without being loud activists.
- The Vanguard Group, Inc. holds approximately 8.53% of shares, totaling over 4.9 million shares as of June 2025.
- BlackRock, Inc. holds about 7.49%, or roughly 4.3 million shares, making it the third-largest holder overall.
- EARNEST Partners, LLC holds a notable 6.51% stake, amounting to over 3.7 million shares.
These large, index-tracking funds are less concerned with day-to-day operations and more focused on capital allocation-specifically, debt reduction and margin expansion. They want to see management deliver on the promise of a best-in-class consumer goods company, which is why the 2025 fiscal year performance was so crucial. The full-year non-GAAP adjusted gross margin rate hit 31.2%, exceeding the 30% target, which definitely keeps these big funds happy. That's a strong signal they're executing.
Recent Moves: The Cannabis Volatility Trade
The most telling investor activity in fiscal year 2025 centered on the company's cannabis-related business, Hawthorne Gardening. You saw a clear split between funds that were exiting the volatility and those who saw a buying opportunity in the core business.
In the second quarter of 2025, two major institutional funds made huge, opposing moves that tell the whole story:
| Investor | Q2 2025 Move | Shares Traded | Estimated Value of Trade |
|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | Substantially Removed (99.0% decrease) | 1,843,649 | $121,607,088 |
| FMR LLC | Massively Added (5793.7% increase) | 1,560,872 | $102,955,117 |
KAYNE ANDERSON RUDNICK essentially liquidated their position, likely due to continued uncertainty in the cannabis sector. But FMR LLC saw the same volatility and decided to buy in big, betting on the core lawn and garden business and the eventual separation. This is a classic 'sum-of-the-parts' trade, where one investor exits a messy conglomerate and another enters, expecting a clean-up to Breaking Down The Scotts Miracle-Gro Company (SMG) Financial Health: Key Insights for Investors and boost the stock price.
Investor Influence and the Hawthorne Divestiture
The strategic decision to separate the Hawthorne businesses is the clearest example of investor influence in 2025. The core message from the market was simple: the cannabis volatility was depressing the valuation of the stable consumer lawn and garden segment. The company listened.
The first official step was the April 2025 transfer of The Hawthorne Collective, Inc., the cannabis investment arm, to an independent strategic partner in exchange for an interest-bearing promissory note. This was an immediate way to reduce the impact of the cannabis sector's volatility on the stock. Management has also committed to separating the larger Hawthorne Gardening Company by the end of fiscal 2025. This move is expected to drive the company's debt leverage down from just over 4x in fiscal 2025 to safely into the 3s for fiscal 2026, which is defintely what debt-conscious institutional investors want to see.
Here's the quick math: isolating the profitable, high-margin consumer business should expand the price-to-earnings multiple, which is the ultimate goal for shareholders. Your action item is to watch for the final details of the Hawthorne separation; that event will be the next major catalyst for the stock.
Market Impact and Investor Sentiment
You're looking at The Scotts Miracle-Gro Company (SMG) right now and seeing a mixed signal, and honestly, that's the right read. While the professional analyst community has a clear 'Strong Buy' consensus, the near-term technical sentiment is still weak. This split tells you that the market is wrestling with a turnaround story: the company is delivering on profitability, but the top-line sales growth remains a concern for some traders.
Institutional investors, the big money, are definitely committed; they own about 74.07% of the stock. What this estimate hides is that corporate insider sentiment has been negative, with more selling than buying over the last quarter. You need to watch that divergence-it's a classic signal of a company in transition, where operational performance is improving faster than general market confidence.
The Mixed Signal on Investor Sentiment
The sentiment is a tug-of-war between fundamental strength and market caution. The average analyst rating is a 'Strong Buy,' with a consensus price target of $69.50, which suggests a significant upside of over 30% from the current stock price.
But, to be fair, technical analysts see a different picture. As of mid-November 2025, some models indicate a 'Weak' near-term sentiment, suggesting the stock might struggle to gain momentum immediately. This is why you see the stock trading at a high price-to-earnings ratio of 60.9x compared to its peers, sparking a debate between value-focused investors and those worried about valuation. It's a classic case of bulls betting on the future earnings and bears focusing on the present valuation.
- Average Analyst Target: $69.50 per share.
- Institutional Ownership: Approximately 74.07% of shares.
- Near-Term Technical Signal: Weak.
Recent Market Reactions to Financial Health
The most important recent market reaction came right after the November 5, 2025, fiscal year-end earnings report. The stock was up 5.5% following the announcement of strong full-year results and a dividend boost. This move clearly shows investors are prioritizing operational efficiency and margin recovery over sales volume.
Here's the quick math: The Scotts Miracle-Gro Company reported full fiscal year 2025 net sales of $3.41 billion, a 4% decrease from the prior year. However, adjusted gross margin expanded by 490 basis points to 31.2%, and adjusted EPS grew by a massive 63% to $3.74 per share. That margin surge is what the market is cheering. They delivered a quarterly cash dividend of $0.66 per share, payable in December 2025, reinforcing their commitment to shareholder returns. You can dive deeper into this financial shift in Breaking Down The Scotts Miracle-Gro Company (SMG) Financial Health: Key Insights for Investors.
| Key Fiscal Year 2025 Financial Metric | Value | Significance |
|---|---|---|
| Full-Year Net Sales | $3.41 billion | 4% decrease year-over-year |
| Adjusted EPS | $3.74 | 63% growth from FY2024 |
| Adjusted Gross Margin Rate | 31.2% | Increased 490 basis points |
| Adjusted EBITDA | $581.1 million | 14% increase year-over-year |
Analyst Perspectives and Key Investor Impact
Analysts are mostly bullish because they see a clear path to higher profitability, driven by management's strategic focus. The key is the shift from low-margin products to higher-margin branded fertilizers and the aggressive cost-saving program. The company completed $75 million in supply chain cost savings during fiscal 2025, with plans for an additional $75 million over the next two fiscal years.
The biggest near-term catalyst for institutional investors is the planned capital return. Management has signaled a multi-year share buyback program, targeting between $500 million and $1 billion, starting in fiscal year 2026. This kind of move defintely boosts earnings per share and signals a return to a more shareholder-friendly capital structure now that the balance sheet is improving. Key institutional holders like Vanguard Group Inc, BlackRock, Inc., and State Street Corp are watching these actions closely, as they directly impact the long-term value of their significant stakes. The focus is on execution now.

The Scotts Miracle-Gro Company (SMG) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.